Human immunodeficiency virus: a global problem with ongoing implications for transfusion medicine
2008; Wiley; Volume: 3; Issue: 1 Linguagem: Inglês
10.1111/j.1751-2824.2008.00161.x
ISSN1751-2824
Autores Tópico(s)Hepatitis C virus research
ResumoISBT Science SeriesVolume 3, Issue 1 p. 170-174 Human immunodeficiency virus: a global problem with ongoing implications for transfusion medicine M. P. Busch, M. P. Busch Blood Systems Research Institute, University of California, San Francisco, San Francisco, CA 94118, USASearch for more papers by this author M. P. Busch, M. P. Busch Blood Systems Research Institute, University of California, San Francisco, San Francisco, CA 94118, USASearch for more papers by this author First published: 22 April 2008 https://doi.org/10.1111/j.1751-2824.2008.00161.x : M. P. Busch, Blood Systems Research Institute, University of California, 270 Masonic Avenue, San Francisco, San Francisco, CA 94118, USAE-mail: [email protected] Conflict of Interests: M.P.B. declares no conflict of interests. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 UNAIDS: 2007 AIDS Epidemic Update; available at http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/ 2 Fauci AS: 25 years of HIV/AIDS science: reaching the poor with research advances. Cell 2007; 131: 429–432 3 Keele BF, Van Heuverswyn F, Li Y, Bailes E, Takehisa J, Santiago ML, Bibollet-Ruche F, Chen Y, Wain LV, Liegeois F, Loul S, Ngole EM, Bienvenue Y, Delaporte E, Brookfield JF, Sharp PM, Shaw GM, Peeters M, Hahn BH: Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science 2006: 313: 523–526 4 Van Heuverswyn F, Li Y, Neel C, Bailes E, Keele BF, Liu W, Loul S, Butel C, Liegeois F, Bienvenue Y, Ngolle EM, Sharp PM, Shaw GM, Delaporte E, Hahn BH, Peeters M: Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006; 444: 164 5 Sucupira MC, Caseiro MM, Alves K, Tescarollo G, Janini LM, Sabino EC, Castelo A, Page-Shafer K, Diaz RS: High levels of primary antiretroviral resistance genotypic mutations and B/F recombinants in Santos. Brazil AIDS Patient Care STDS 2007; 21: 116–128 6 Johnston MI, Fauci AS: An HIV vaccine – evolving concepts [Review]. N Engl J Med 2007; 356: 2073–2081 7 Frost SD, Liu Y, Pond SL, Chappey C, Wrin T, Petropoulos CJ, Little SJ, Richman DD: Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J Virol 2005; 79: 6523–6527 8 Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ: Incidence of HIV superinfection following primary infection. JAMA 2004; 292: 1177–1178 9 Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, Collier AC, Corey L, Fauci AS: Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis 2007; 195: 1762–1764 10 Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S; AIEDRP Network: A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194: 725–733 11 Busch MP. Transfusion-transmitted viral infections: building bridges to transfusion medicine to reduce risks and understand pathogenesis. Transfusion 2006; 46: 1624–1640 12 Busch MP, Glynn SA, Stramer SL, Strong DM, Caglioti S, Wright DJ, Pappalardo B, Kleinman SH; NHLBI-REDS NAT Study Group: A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005; 45: 254–264 13 O’Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC: Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services. Transfusion 2007; 47: 316–325 14 Hourfar MK, Brixner V, Busch MP, Geusendam G, Gubbe K, Jork C, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Schottstedt V, Seifried E, Weber-Schehl M, Wright DJ, for the German Red Cross Blood Donor Services with NAT-testing: results of screening more than 30 million blood donations for HIV-1, HCV, and HBV. Transfusion 2008 15 Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Sivilotti ML, Smaill F: Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007; 47: 2338–2347 16 WHO: Blood Transfusion Safety; available at http://www.who.int/bloodsafety/en/ 17 Laperche S: Advances and cost/benefit of antigen-antibody combination assays for blood donor screening. Transfusion 2008 18 Ly TD, Ebel A, Faucher V, Fihman V, Laperche S: Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods 2007; 143: 86–94 19 Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP: Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17: 1871–1879 20 Delwart E, Magierowska M, Royz M, Foley B, Peddada L, Smith R, Heldebrant C, Conrad A, Busch M: Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 2002; 16: 189–195 21 Keele B, Giorgi E, Salazar-Gonzalez J, Gao F, Swanstrom R, Busch M, Haynes B, Korber B, Hahn B, Shaw G: Identification and characterization of transmitted and early founder viruses in primary HIV-1 infection. Oral Presentation #153. Symposium Session 44, Frontiers in Vaccine Research. 15th Conf on Retroviruses & Opportunistic Infections (CROI), Boston, MA, USA, 3–6 February 2008; available at http://www.retroconference.org/2008/Abstracts/33485.htm 22 Norris PJ, Pappalardo BL, Custer B, Spotts G, Hecht FM, Busch MP: Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses 2006; 22: 757–762 23 Ma Z-M, Piatak M, Fritts L, Lu D, Lifson J, Busch M, Miller CJ: Transmission of simian immunodeficiency virus by plasma collected prior to detectable viremia, and relative infectivity of ramp-up versus chronic stage plasma. Poster #285 Session 56, Viral Transmission: Molecular Studies. 15th Conf on Retroviruses & Opportunistic Infections (CROI), Boston, MA, USA, 3–6 February 2008; available at http://www.retroconference.org/2008/Abstracts/33291.htm 24 Hatano H, Delwart E, Norris PJ, Hoh R, Busch MP, Martin JM, Deeks SG: Longitudinal measurements of ultra-sensitive plasma HIV RNA and quantitative antibody levels in HIV-1 infected individuals who naturally maintain viral loads below the limit of conventional detection. Poster #347 Session 63, Studies on Elite Controllers and Exposed Uninfected. 15th Conference on Retroviruses and Opportunistic Infections (CROI). Boston, MA, USA, 3–6 February 2008; available at http://www.retroconference.org/2008/Abstracts/31516.htm 25 Busch MP, Hecht FM: Nucleic acid amplification testing for diagnosis of acute HIV infection: has the time come? AIDS 2005; 19: 1317–1319 26 Pilcher CD, Fiscus SA, Nguyen TQ, Foust E, Wolf L, Williams D, Ashby R, O'Dowd JO, McPherson JT, Stalzer B, Hightow L, Miller WC, Eron JJ, Jr, Cohen MS, Leone PA: Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352: 1873–1883 27 McDougal JS, Pilcher CD, Parekh BS, Gershy-Damet G, Branson BM, Marsh K, Wiktor SZ: Surveillance for HIV-1 incidence using tests for recent infection in resource-constrained countries [Review]. AIDS 2005; 19 (Suppl. 2): S25–S30 28 Busch MP: Lessons and opportunities from epidemiologic and molecular investigations of infected blood donors. Transfusion 2006; 46: 1663–1666 29 Delwart E, Kuhns MC, Busch MP: Surveillance of the genetic variation in incident HIV, HCV, and HBV infections in blood and plasma donors: implications for blood safety, diagnostics, treatment, and molecular epidemiology. J Med Virol 2006; 78: s30–s35 30 Hecht F, Pilcher C: Lessons from primary HIV infection. Focus 2007; 22: 1–5 Volume3, Issue1Special Issue: State of the Art Presentations XXXth International Congress of the ISBTJune 2008Pages 170-174 ReferencesRelatedInformation
Referência(s)